Consultation on acynonapyr and Kodama Miticide, Proposed Registration Decision PRD2026-03

Current status: Open

Opened on 10 February 2026 and will close for consultation on 12 March 2026.

Health Canada’s Pest Management Regulatory Agency (PMRA) is proposing registration for the sale and use of Acynonapyr Technical and Kodama Miticide, containing the active ingredient acynonapyr, to control Tetranychid mites on Crop Group 11-09: Pome Fruits.

An evaluation of available scientific information found that, under the approved conditions of use, the health and environmental risks and the value of the pest control products are acceptable.

How to get involved

This consultation is open for comment from 10 February 2026 to 12 March 2026 (30 calendar days). Open the “Consultation Summary” to access the document.

If you would like to comment, see the Pest Management Regulatory Agency Publications Section page for contact information. Please be sure to include the title of the consultation document on which you are commenting.

Health Canada will consider any written comments received from the public that are directly related to this proposed decision, such as comments directed to the science evaluation, in response to PRD2026-03 up to 30 days from the date of publication of this document (by 12 March 2026) before making a final decision on the proposed registration for acynonapyr and Kodama Miticide.

If more time is required to provide comments, a request for an extension of an additional 15 days can be made. Your request must be submitted in writing to the PMRA’s Publications Section within the 30-day consultation period.

Reporting to Canadians

Health Canada will make the results of this consultation available on this website. Once the decision for acynonapyr and Kodama Miticide is finalized, the PMRA will post a Registration Decision on the Pesticides and Pest Management Reports and Publications portion of Canada.ca.

If you have any questions, contact the Pest Management Information Service.

Interested in our other consultations? Sign up and stay informed about topics that matter to you.

Page details

2026-02-10